In November of 2014, a partnership between the ALS Society of Canada and Brain Canada resulted in the largest one-time investment in research in the history of the ALS Society of Canada: a $20-million investment in a national research program. The Brain Canada and ALS Society of Canada partnership encompasses three jointly- funded programs; Arthur J. Hudson Grants for Translational Research; Career Transition Grant; and the Discovery Awards.
ALS Hudson Award
The program was designed to bring together researchers from across the country to accelerate therapeutic development by: 1) identifying and testing a relevant therapeutic target or candidate therapy and/or 2) addressing critical needs for early diagnosis and biomonitoring of clinical progression applied to clinical research. Research in all stages of development is welcomed, from basic/preclinical to phase I, II and III clinical trials.
The Discovery Grants program has been established to encourage new basic research focused on identifying causes of, or treatments for ALS and/or related neurological diseases, including primary lateral sclerosis, progressive muscular atrophy, and ALS/FTLD (ALS/frontotemporal lobar dementia). The spirit of this program is “high risk/high reward” and is aimed at independent investigator(s) proposing a novel research approach, supported by a sound rationale and feasible experimental plan, but not necessarily preliminary data.
Career Transition Award competition
This program aims to identify and engage rising stars pursuing innovative research in labs and academic institutions in Canada. This award has the long-term goal of developing the next generation of scientists across various disciplines within basic and clinical sciences, contributing to knowledge generation and translation in ALS. The award will provide the necessary support to senior postdoctoral trainees as well as recently hired junior faculty members to secure or maintain a faculty job in Canada.